ºÚÁϳԹÏ×ÊÔ´

Conferences and seminars

Neuro-SysMed Seminar April 22, 2026

Logoen til seminarene.
Photo: Neuro-SysMed

Welcome to the Neuro-SysMed monthly seminar series! Join us at the auditorium in Armauer Hansens Hus at 11:30 - 13:00 (lunch from 11:30 - 12:00). The topic this time will be from Neuro-SysMed's ALS Node.

Speakers

Ole-Bjørn Tysnes og Mari Klauset Holtom from Neuro-SysMed's .

Topic

"Challenges in running a multicentre RCT. The NO-ALS study experience."

Registration

. The deadline if you'd like to join the lunch is April 20 at 11.00.Ìý

Where and when

Place: The auditorium in Armauer Hansens Hus

When: April 22, 2026, at 11:30 - 13:00 (lunsj 11:30 - 12:00).

Abstract

There are currently no neuroprotective treatments for Amyotrophic lateral sclerosis (ALS) with a significant impact on disease progression.  Previous research by the PD Node and others has nominated NAD-replenishment therapy as a promising neuroprotective strategy against neurodegeneration. Moreover, prior to the NO-ALS study, a published small trial using a combination of the NAD-precursor nicotinamide riboside (NR) and sirtuin booster pterostilbene, showed encouraging findings in ALS. To test the potential of this strategy as a neuroprotective therapy for ALS, Neuro-SysMed Centre for Clinical Treatment Research initiated the NO-ALS trial, a phase-II, multicentre, double-blinded randomized trial of oral NR and pterostilbene inn early ALS. At this seminar, Professor Ole-Bjørn Tysnes and Study Nurse Mari Klauset Holtom from Neuro-SysMed's ALS node will discuss experiences from the NO-ALS trial, and discuss challenges in running a multicentre randomized clinical trial.Ìý

NEUROSYSM920

Neuro-SysMed's seminar series is open to all and is, in addition, part of a 3 ECTS course in Neuro-SysMed's Research School, with subject code .

The objectives of the seminars at the Neuro-SysMed Research School for Translational Neuroscience are to provide knowledge into the research field of the disciplines involved in Neuro-SysMed, and the treatment strategies for patients with MS, PD, ALS, and dementia.

The course entails monthly participation in the seminar series, a two-day symposium, and the submission of two written reports. Students are also required to present their own research or a self-chosen scientific topic at the symposium. Read more about the course code on the student webpages.Ìý